| Sorafenib in Treating Patients With Metastatic Breast Cancer (NCT00096434) | National Cancer Institute (NCI) | 2004-09-01 |
| SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells (NCT00091130) | National Cancer Institute (NCI) | 2004-09-01 |
| Sorafenib and Interferon Alfa in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00101114) | National Cancer Institute (NCI) | 2004-09-01 |
| Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas (NCT00089089) | National Cancer Institute (NCI) | 2004-09-01 |
| Ixabepilone in Treating Patients With Metastatic Prostate Cancer (NCT00087139) | National Cancer Institute (NCI) | 2004-09-01 |
| Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer (NCT00093756) | National Cancer Institute (NCI) | 2004-09-01 |
| Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission (NCT00093470) | National Cancer Institute (NCI) | 2004-08-18 |
| Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia (NCT00070499) | National Cancer Institute (NCI) | 2004-08-15 |
| Apolizumab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00089154) | National Cancer Institute (NCI) | 2004-08-01 |
| Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00091338) | National Cancer Institute (NCI) | 2004-08-01 |
| Vaccine Therapy, Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed With Surgery (NCT00091039) | National Cancer Institute (NCI) | 2004-08-01 |
| Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer (NCT00096200) | National Cancer Institute (NCI) | 2004-08-01 |
| Phase III Trial Of Docetaxel Versus Docetaxel Plus ZD1839 In Head And Neck Cancer (NCT00088907) | National Cancer Institute (NCI) | 2004-08-01 |
| Genetic Analysis of Psoriasis and Psoriatic Arthritis (NCT00341809) | National Cancer Institute (NCI) | 2004-07-30 |
| Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas (NCT00076102) | National Cancer Institute (NCI) | 2004-07-21 |
| PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer (NCT00088413) | National Cancer Institute (NCI) | 2004-07-21 |
| 17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease (NCT00088374) | National Cancer Institute (NCI) | 2004-07-01 |
| 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas (NCT00089271) | National Cancer Institute (NCI) | 2004-07-01 |
| Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia (NCT00089349) | National Cancer Institute (NCI) | 2004-07-01 |
| Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer (NCT00091026) | National Cancer Institute (NCI) | 2004-07-01 |
| Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00091117) | National Cancer Institute (NCI) | 2004-07-01 |
| A Phase II Trial of Triapine (NSC #663249) in Combination With Gemcitabine as Second Line Treatment of Non-Small Cell Lung Cancer (NCT00077350) | National Cancer Institute (NCI) | 2004-07-01 |
| Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas (NCT00085371) | National Cancer Institute (NCI) | 2004-07-01 |
| Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362) | National Cancer Institute (NCI) | 2004-07-01 |
| Cilengitide in Treating Patients With Acute Myeloid Leukemia (NCT00089388) | National Cancer Institute (NCI) | 2004-07-01 |
| Effect of Genetic Differences on Levels of Water Disinfection Byproducts in Blood After Showering (NCT00340535) | National Cancer Institute (NCI) | 2004-06-23 |
| Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme (NCT00083512) | National Cancer Institute (NCI) | 2004-06-22 |
| Feasibility Study for Prospective Diet and Lifestyle Cohorts in Delhi, Kerala, and Kolkota, India (NCT00341536) | National Cancer Institute (NCI) | 2004-06-17 |
| Preoperative Thalidomide With Radiation Therapy For Patients With Low-Grade Primary Soft Tissue Sarcoma or Thalidomide With Radiation Therapy and Chemotherapy For Patients With High-Grade or Intermediate-Grade Primary Soft Tissue Sarcoma of the Arm, Leg, or Body Wall (NCT00089544) | National Cancer Institute (NCI) | 2004-06-17 |
| Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma (NCT00088855) | National Cancer Institute (NCI) | 2004-06-15 |
| Data Collection, Clinical Care and Interventions in CCR, NCI (NCT00923065) | National Cancer Institute (NCI) | 2004-06-10 |
| Relationship of Genetic Differences to the Development of Chromosome Abnormalities (NCT00481793) | National Cancer Institute (NCI) | 2004-06-09 |
| CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor (NCT00087074) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy in Treating Patients With Metastatic Melanoma (NCT00087373) | National Cancer Institute (NCI) | 2004-06-01 |
| Effect of Tenofovir DF on Bone Metabolism in Children (NCT00088309) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer (NCT00088933) | National Cancer Institute (NCI) | 2004-06-01 |
| S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer (NCT00087152) | National Cancer Institute (NCI) | 2004-06-01 |
| Paclitaxel, Bevacizumab And Adjuvant Intraperitoneal Carboplatin in Treating Patients Who Had Initial Debulking Surgery for Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer (NCT00079430) | National Cancer Institute (NCI) | 2004-06-01 |
| Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors (NCT00086970) | National Cancer Institute (NCI) | 2004-06-01 |
| Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT00088894) | National Cancer Institute (NCI) | 2004-06-01 |
| Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck (NCT00077428) | National Cancer Institute (NCI) | 2004-06-01 |
| Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer (NCT00080899) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma (NCT00089063) | National Cancer Institute (NCI) | 2004-06-01 |
| MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma (NCT00089076) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy in Preventing Cervical Cancer in Patients With Cervical Intraepithelial Neoplasia (NCT00054041) | National Cancer Institute (NCI) | 2004-06-01 |
| Tanespimycin in Treating Patients With Stage III-IV Melanoma (NCT00087386) | National Cancer Institute (NCI) | 2004-06-01 |
| Genetic and Protein Profiling in Normal and Cancerous Breast Tissue (NCT00083733) | National Cancer Institute (NCI) | 2004-05-27 |
| Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors (NCT00085553) | National Cancer Institute (NCI) | 2004-05-20 |
| Breast Cancer, Breast Disease, and Pesticides (NCT00341315) | National Cancer Institute (NCI) | 2004-05-17 |
| PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy (NCT00082368) | National Cancer Institute (NCI) | 2004-05-16 |
| Oblimersen, Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (NCT00086944) | National Cancer Institute (NCI) | 2004-05-01 |
| Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 (NCT00085293) | National Cancer Institute (NCI) | 2004-05-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor (NCT00087217) | National Cancer Institute (NCI) | 2004-05-01 |
| Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (NCT00084630) | National Cancer Institute (NCI) | 2004-05-01 |
| Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer (NCT00072176) | National Cancer Institute (NCI) | 2004-05-01 |
| Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia (NCT00087204) | National Cancer Institute (NCI) | 2004-05-01 |
| Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer (NCT00086827) | National Cancer Institute (NCI) | 2004-05-01 |
| GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors (NCT00084643) | National Cancer Institute (NCI) | 2004-05-01 |
| Rebeccamycin Analog and Oxaliplatin in Treating Patients With Refractory Solid Tumors (NCT00086983) | National Cancer Institute (NCI) | 2004-05-01 |
| Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer (NCT00077363) | National Cancer Institute (NCI) | 2004-05-01 |
| CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00086840) | National Cancer Institute (NCI) | 2004-05-01 |
| Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer) (NCT00085358) | National Cancer Institute (NCI) | 2004-05-01 |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191) | National Cancer Institute (NCI) | 2004-05-01 |
| Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas (NCT00080535) | National Cancer Institute (NCI) | 2004-04-30 |
| Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer (NCT00082147) | National Cancer Institute (NCI) | 2004-04-29 |
| Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors (NCT00081848) | National Cancer Institute (NCI) | 2004-04-20 |
| Early Detection of Barrett's Esophagus (NCT00081354) | National Cancer Institute (NCI) | 2004-04-06 |
| UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas (NCT00082017) | National Cancer Institute (NCI) | 2004-04-05 |
| LMB-2 Immunotoxin in Treating Young Patients With Relapsed or Refractory Leukemia or Lymphoma (NCT00085150) | National Cancer Institute (NCI) | 2004-04-01 |
| Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00084604) | National Cancer Institute (NCI) | 2004-04-01 |
| Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck (NCT00081211) | National Cancer Institute (NCI) | 2004-04-01 |
| Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors (NCT00079352) | National Cancer Institute (NCI) | 2004-04-01 |
| Diindolylmethane in Preventing Cancer in Healthy Volunteers (NCT00784394) | National Cancer Institute (NCI) | 2004-04-01 |
| Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00083122) | National Cancer Institute (NCI) | 2004-04-01 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer (NCT00070122) | National Cancer Institute (NCI) | 2004-04-01 |
| CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase (NCT00084916) | National Cancer Institute (NCI) | 2004-04-01 |
| Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy (NCT00084487) | National Cancer Institute (NCI) | 2004-04-01 |
| Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer (NCT00084981) | National Cancer Institute (NCI) | 2004-04-01 |
| Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00082888) | National Cancer Institute (NCI) | 2004-03-24 |
| Molecular Staging of Endometrial Cancer (NCT00340808) | National Cancer Institute (NCI) | 2004-03-19 |
| Prognostic Value of a Positive RT-PCR Test in Patients With Ewing Sarcoma (NCT00339898) | National Cancer Institute (NCI) | 2004-03-12 |
| Stem Cell Transplant With Th2/Tc2 Cells to Treat Advanced Breast Cancer (NCT00079625) | National Cancer Institute (NCI) | 2004-03-05 |
| Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia (NCT00076180) | National Cancer Institute (NCI) | 2004-03-01 |
| Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00082966) | National Cancer Institute (NCI) | 2004-03-01 |
| Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma (NCT00084617) | National Cancer Institute (NCI) | 2004-03-01 |
| A Phase II Trial of STI571 in the Treatment of Metastatic Gastric Cancer (NCT00068380) | National Cancer Institute (NCI) | 2004-03-01 |
| Alanosine in Treating Patients With Progressive or Recurrent Malignant Gliomas (NCT00075894) | National Cancer Institute (NCI) | 2004-03-01 |
| Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers (NCT02090933) | National Cancer Institute (NCI) | 2004-03-01 |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia (NCT00079404) | National Cancer Institute (NCI) | 2004-03-01 |
| Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00084877) | National Cancer Institute (NCI) | 2004-03-01 |
| CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00290472) | National Cancer Institute (NCI) | 2004-03-01 |
| Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms (NCT00082784) | National Cancer Institute (NCI) | 2004-03-01 |
| T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant (NCT00089180) | National Cancer Institute (NCI) | 2004-03-01 |
| Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma (NCT00080353) | National Cancer Institute (NCI) | 2004-03-01 |
| Cilengitide in Treating Patients With Unresectable or Metastatic Melanoma (NCT00082875) | National Cancer Institute (NCI) | 2004-03-01 |
| S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma (NCT00080847) | National Cancer Institute (NCI) | 2004-03-01 |
| Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer (NCT00082914) | National Cancer Institute (NCI) | 2004-03-01 |
| Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT00084461) | National Cancer Institute (NCI) | 2004-03-01 |
| Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer (NCT00083109) | National Cancer Institute (NCI) | 2004-03-01 |
| Doxorubicin and Bortezomib in Treating Patients With Liver Cancer (NCT00083226) | National Cancer Institute (NCI) | 2004-03-01 |